11-47167956-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032389.6(ARFGAP2):āc.1158G>Cā(p.Glu386Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000125 in 1,613,814 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_032389.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152178Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000678 AC: 17AN: 250906Hom.: 0 AF XY: 0.0000737 AC XY: 10AN XY: 135628
GnomAD4 exome AF: 0.000135 AC: 197AN: 1461636Hom.: 0 Cov.: 33 AF XY: 0.000135 AC XY: 98AN XY: 727092
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152178Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1158G>C (p.E386D) alteration is located in exon 12 (coding exon 12) of the ARFGAP2 gene. This alteration results from a G to C substitution at nucleotide position 1158, causing the glutamic acid (E) at amino acid position 386 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at